Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients
2015
Objectives
Demonstrate the safety and effectiveness of highly purified CD133+ autologous stem cells in critical limb ischemia (CLI).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
21
References
21
Citations
NaN
KQI